Leichlingen, Germany

Jochen Kalbe


 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 63(Granted Patents)


Location History:

  • Essen, DE (1995 - 1998)
  • Leichlingen, DE (1999 - 2018)

Company Filing History:


Years Active: 1995-2018

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Jochen Kalbe: Innovator in Veterinary and Cancer Treatment Solutions

Introduction

Jochen Kalbe is a prominent inventor based in Leichlingen, Germany, known for his significant contributions to veterinary medicine and cancer treatment. With a total of 16 patents to his name, Kalbe has made remarkable strides in developing innovative solutions for controlling parasites in animals and treating cancer in both humans and animals.

Latest Patents

One of Kalbe's latest patents focuses on agents for the control of parasites on animals. This invention involves active substances from the group of phenylpyrazoles combined with vitamin E or its derivatives, such as vitamin E acetate. The agents are particularly effective against ectoparasites like fleas, ticks, and sand flies in pets, including dogs, cats, and ferrets. Another notable patent pertains to novel isocyanate and isothiocyanate compounds for cancer treatment. These compounds are part of pharmaceutical compositions that demonstrate improved therapeutic breadth, resulting in fewer side effects while maintaining high anti-tumor activity.

Career Highlights

Throughout his career, Jochen Kalbe has worked with esteemed companies such as Bayer Aktiengesellschaft and Wolff Walsrode AG. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Kalbe has collaborated with notable colleagues, including Rainhard Koch and Hanns-Peter Muller, further enhancing his work in the field of innovation.

Conclusion

Jochen Kalbe's contributions to veterinary medicine and cancer treatment exemplify his dedication to innovation and improving health outcomes. His patents reflect a commitment to developing effective solutions for pressing medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…